Szeyi Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Szeyi Ng has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Anna M. Kirby
Royal Marsden NHS Foundation Trust, Sutton, UK
2 shared publications - Charlotte E. Coles
Department of Oncology, University of Cambridge, Cambridge, CB2 0QQ, UK
2 shared publications - Cliona Clare Kirwan
Institute of Cancer Sciences, University of Manchester, University Hospital of South Manchester, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Oxford Road, Manchester M13 9PL, United Kingdom
2 shared publications - Judith M. Bliss
Clinical Trials and Statistics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom
2 shared publications - Lucy Kilburn
Clinical Trials and Statistics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom
2 shared publications - Mark Sydenham
Clinical Trials and Statistics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom
2 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 214, 111301
Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials
- 27 November 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 214, 111301
Open AccessBaseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials
- Open Access
- 19 August 2025
- Published by Springer Nature in BJC Reports
- Vol. 3 (1) , 1-12
Hidden costs and unmet supportive care needs among individuals with experience of breast cancer and their carers in the United Kingdom
Background: The impact of cancer transcends physical health, affecting mental wellbeing, financial stability, and ability to perform daily tasks, influencing not only patients but also the broader community. Methods: Online anonymous surveys (24/01/2023–03/03/2023) were disseminated via charities to individuals treated for breast cancer in the UK and their carers. Multivariable ordered logistic regression models were used to investigate demographic, cancer-related and employment factors associated with physical, wellbeing and financial Quality-of-Life (QoL). Results: 470 and 136 participants reported primary (PBC) and metastatic (MBC) breast cancer, respectively. 27% PBC and 35% MBC participants reported experience of financial problems. 17% PBC and 47% MBC participants reported trouble fulfilling caring responsibilities at the time of survey completion. For PBC participants, reports of financial problems were associated with difficulties seeking help for physical or wellbeing issues, which were associated with worse physical and wellbeing QoL. Financial problems, and other challenges were more commonly reported among MBC participants. These factors may impact QoL similarly, so there was no evidence of specific explanatory factors for MBC participants. Conclusions: Better understanding of wider impact of breast cancer could lead to better policy and support. Future clinical trials should incorporate more comprehensive assessment of breast cancer’s wider effects.
- 19 August 2025
- Published by Springer Nature in BJC Reports
- Vol. 3 (1) , 1-12
Open AccessHidden costs and unmet supportive care needs among individuals with experience of breast cancer and their carers in the United Kingdom
Background: The impact of cancer transcends physical health, affecting mental wellbeing, financial stability, and ability to perform daily tasks, influencing not only patients but also the broader community. Methods: Online anonymous surveys (24/01/2023–03/03/2023) were disseminated via charities to individuals treated for breast cancer in the UK and their carers. Multivariable ordered logistic regression models were used to investigate demographic, cancer-related and employment factors associated with physical, wellbeing and financial Quality-of-Life (QoL). Results: 470 and 136 participants reported primary (PBC) and metastatic (MBC) breast cancer, respectively. 27% PBC and 35% MBC participants reported experience of financial problems. 17% PBC and 47% MBC participants reported trouble fulfilling caring responsibilities at the time of survey completion. For PBC participants, reports of financial problems were associated with difficulties seeking help for physical or wellbeing issues, which were associated with worse physical and wellbeing QoL. Financial problems, and other challenges were more commonly reported among MBC participants. These factors may impact QoL similarly, so there was no evidence of specific explanatory factors for MBC participants. Conclusions: Better understanding of wider impact of breast cancer could lead to better policy and support. Future clinical trials should incorporate more comprehensive assessment of breast cancer’s wider effects.
- Open Access
- 23 July 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 211, 111056
Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial
- 23 July 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 211, 111056
Open AccessFive-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial